What Is PCOS? Understanding Polycystic Ovary Syndrome — Symptoms, Causes, and Why "Cysts" Is a Misleading Name

Short Answer

Polycystic ovary syndrome (PCOS) is a common hormonal condition in people who menstruate, and it is often described as the most common endocrine disorder in reproductive-age women. The name is the first trap: PCOS is not mainly a disease of ovarian "cysts." In adults, diagnosis usually follows the Rotterdam criteria: you need at least two of three features — irregular or absent ovulation, signs or blood-test evidence of high androgens such as acne or unwanted hair growth, and polycystic ovarian morphology on ultrasound, after other causes have been ruled out. The "cysts" behind that third feature are usually many small, immature follicles seen on imaging, not true cysts — and you can have PCOS without that ultrasound finding. (Yu et al., *Am. J. Obstet. Gynecol.*, 2023)

That adult 2-of-3 rule is also why PCOS can look so different from person to person: one body may show it through missing periods and acne, another through ovulation problems and ultrasound findings, another through high androgens and metabolic changes. Many people with PCOS also have insulin resistance, which is why PCOS is not only about periods or fertility; it can connect to longer-term metabolic health, including higher risk of type 2 diabetes and cardiovascular risk factors. There is no single blood test that "proves" PCOS by itself, and PCOS is managed rather than cured. (WHO)

Adolescents need a more cautious diagnosis, because irregular cycles, acne, and polycystic-looking ovaries can overlap with normal puberty. The 2023 International PCOS Guideline and adolescent-specific recommendations say that, in adolescents, diagnosis should be based on both irregular menstrual cycles and clinical or biochemical hyperandrogenism after excluding conditions that mimic PCOS; ultrasound and AMH are not recommended for adolescent diagnosis because they can overcall PCOS. ACOG's adolescent hyperandrogenism guidance also frames acne and hirsutism as symptoms that deserve evaluation, with PCOS included in the differential diagnosis rather than assumed automatically. (Peña et al., adolescent PCOS recommendations)

PCOS at a glance

What PCOS actually is (and why the name is misleading)

Polycystic ovary syndrome is a hormonal and metabolic condition, not a disease defined by ovarian cysts. In the research literature, PCOS is described as being "characterized by menstrual irregularities, hyperandrogenism, and polycystic ovarian morphology" (*Frontiers in Medicine*, 2026), and it is "the most common endocrine irregularity in people who are assigned-female-at-birth and are of reproductive age" (*Sociology of Health & Illness*, 2026, PMC13101570). In plain English: the problem is not that your ovaries are "full of cysts." The problem is that the signaling between reproductive hormones, ovulation, and metabolism is out of rhythm. The ovaries are one place that rhythm can show up — not the whole story and not the root cause. (Cleveland Clinic)

The word "polycystic" is where most of the fear starts. On ultrasound, ovaries in PCOS can look enlarged or show many small sacs around the edge. Those sacs are follicles — the tiny structures that hold immature eggs. In a typical cycle, one follicle becomes dominant and releases an egg; in PCOS, ovulation may be irregular or absent, so several immature follicles can remain visible instead of moving through the usual ovulation process. That is why the image can look "cystic," even though these are not the painful ovarian cysts people often imagine. (Mayo Clinic)

That distinction matters. You do not need surgery to "remove the cysts" just because an ultrasound looks polycystic. And the ultrasound is not the diagnosis by itself. You can have PCOS without dramatic ovarian findings, because polycystic-looking ovaries are only one of the diagnostic features; irregular or missed periods and signs of higher androgens can be enough to fit the pattern. The reverse is also true: polycystic-appearing ovaries alone do not equal the syndrome. Doctors diagnose PCOS by looking for a cluster of findings, not one picture on a screen. (Cleveland Clinic)

Because PCOS is a syndrome — a pattern of related features rather than one single defect — it does not look identical in everyone. For one person, the loudest signal may be skipped periods. For another, acne or facial hair. For another, trouble ovulating, insulin resistance, or an ultrasound finding that only appears during a workup. That variability is exactly why a clinician has to connect the dots and rule out look-alikes before calling it PCOS. (NHS)

How PCOS is defined: the Rotterdam criteria

In adults, PCOS is usually defined with the Rotterdam criteria: you do not need every possible feature of PCOS to have PCOS. You need two of three features — ovulatory dysfunction, hyperandrogenism, or polycystic ovarian morphology — and your clinician also has to rule out other conditions that can look similar, such as thyroid disease, high prolactin, or non-classic congenital adrenal hyperplasia. (Endocrine Society Clinical Practice Guideline, PMC5399492) Research describes the framework directly: PCOS is identified based on the "Rotterdam criteria (oligomenorrhea, hyperandrogenism, or polycystic ovarian morphology according to anti-Müllerian hormone levels)" (*Acta Obstetricia et Gynecologica Scandinavica*, 2026).

Translated into plain language, the three features are:

1. Irregular or absent ovulation — this usually shows up as irregular, infrequent, or missing periods. Your ovaries may not be releasing an egg regularly, so the hormonal rhythm that normally drives a predictable cycle becomes less steady. (Endocrine Society Clinical Practice Guideline, PMC5399492)

2. Hyperandrogenism — this means higher-than-expected androgen activity, either visible on the body or measured in blood work. It can show up as acne, excess facial or body hair, or scalp hair thinning; it can also be "biochemical," meaning your blood test shows elevated androgens even if the signs are less obvious. (Endocrine Society Clinical Practice Guideline, PMC5399492)

3. Polycystic ovarian morphology — this does not mean dangerous ovarian cysts. It means the ovaries have many small follicles on ultrasound. In the 2023 international guideline, anti-Müllerian hormone can also be used as an alternative marker for this ovarian feature in adults, but not as a stand-alone diagnosis. (2023 International PCOS Guideline, PMC10477934)

That "2-of-3" structure is the reason PCOS can look so different from person to person. One person may have irregular periods and high androgens with normal-looking ovaries. Another may have high androgens and polycystic-appearing ovaries, but cycles that are not obviously absent. If irregular cycles and hyperandrogenism are already present, guidelines note that ultrasound or AMH testing is not always needed to make the diagnosis in adults. (Endocrine Society Clinical Practice Guideline, PMC5399492)

Adolescents are handled more carefully because puberty itself can temporarily cause irregular cycles, acne, and ovaries with many follicles. For teens, the 2023 international guideline recommends diagnosing PCOS only when both persistent menstrual irregularity and clinical or biochemical hyperandrogenism are present, after excluding mimicking conditions; ultrasound morphology and AMH should not be used for diagnosis during adolescence because they are not specific enough at that age. (Peña et al., adolescent PCOS recommendations, PMC11899933)

Why it happens: insulin, androgens, and a self-reinforcing loop

PCOS is not just an ovary problem. In many people, the condition is driven by a back-and-forth between higher androgens and insulin resistance — the body having to work harder to move glucose from the blood into cells. Research characterizes PCOS as an "endocrine-metabolic disorder in which reproductive dysfunction coexists with insulin resistance, chronic low-grade inflammation, and heightened oxidative stress" (*Frontiers in Endocrinology*, 2026), and defines it as a disorder that "is defined by insulin resistance, androgen excess, and chronic [low-grade inflammation]" (*Frontiers in Endocrinology*, 2026, PMC12957162). That is why PCOS can show up in the cycle, the skin, fertility, energy, blood sugar, and long-term metabolic health — not because every person has every feature, but because the hormone system and metabolism are connected. The Endocrine Society guideline describes PCOS as having systemic metabolic manifestations, and the 2023 International PCOS Guideline emphasizes metabolic risk as part of PCOS care. (Endocrine Society Clinical Practice Guideline, PMC5399492)

Here is the loop in everyday terms. When cells respond less well to insulin, the pancreas releases more insulin to keep blood sugar in range. Higher insulin can signal ovarian theca cells to make more androgens, and it can also reduce liver production of sex hormone–binding globulin — SHBG, the protein that helps bind sex hormones in the blood. With less SHBG, a larger share of androgen remains "free," meaning it can act more strongly on tissues such as hair follicles, skin, and the ovary. That androgen excess can then make ovulation less regular and may worsen insulin signaling, keeping the loop going. Reviews of PCOS biology describe this insulin-to-androgen pathway, including direct ovarian stimulation and lower SHBG, and Mayo Clinic also lists insulin resistance and excess androgen activity as contributors to PCOS-related risk. (Tata et al., ovarian and extra-ovarian mediators, PMC6192837)

This is also the reason PCOS is linked to more than irregular periods or fertility challenges. The 2023 International PCOS Guideline states that, regardless of age and BMI, people with PCOS have increased risk of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes; Mayo Clinic similarly names type 2 diabetes and heart disease among longer-term health issues associated with PCOS. (2023 International PCOS Guideline, PMC10477934)

Importantly, insulin resistance is common in PCOS but not universal, and it is not limited to people in larger bodies. Lean PCOS exists. A systematic review of gold-standard insulin clamp studies found insulin sensitivity was reduced in PCOS independent of BMI, and a review focused on lean PCOS reported that lean women with PCOS can have greater insulin resistance than BMI-matched people without PCOS. That nuance matters, because "you don't look like you have PCOS" is not medical reasoning — it is a myth with better lighting. (Cassar et al., *Hum. Reprod.*, 2016, PMID 27907900)

Common signs and symptoms

Because PCOS is a syndrome, it does not show up as one neat, identical pattern. For one person, the first clue may be periods that come every few months or disappear. For another, it may be jawline acne, coarse hair on the chin or chest, scalp thinning, or trouble getting pregnant because ovulation is not happening regularly. Others notice weight changes, difficulty losing weight, or dark, velvety patches of skin in body folds — a sign called acanthosis nigricans that can go along with insulin resistance. Mayo Clinic, Cleveland Clinic, and the NHS all describe this same core cluster: irregular or absent periods, signs of higher androgens such as acne, hirsutism and pattern hair loss, fertility difficulty, weight/metabolic changes, and darkened skin folds. (Mayo Clinic)

Mood can be part of the picture too. PCOS is associated with higher rates of anxiety and depression, and symptoms like acne, unwanted hair growth, weight stigma, unpredictable bleeding, and fertility stress can make the emotional load heavier. That does not mean PCOS is "all in your head." It means the hormone-metabolic pattern and the lived experience of the symptoms can affect your nervous system, self-image, and daily life. (Mayo Clinic)

These signs also overlap with many other conditions, which is one reason PCOS can be missed, minimized, or misattributed for years. A pattern tracker can help you bring clearer notes to a clinician — cycle timing, skin changes, hair changes, mood shifts, weight changes, and pregnancy attempts — but it cannot diagnose PCOS by itself. Symptoms are covered in depth on our [PCOS symptoms page](/pcos/symptoms/).

How PCOS is diagnosed

PCOS is not confirmed by one "PCOS blood test." It's diagnosed by putting together a pattern in your body: how often you ovulate, whether there are clinical or blood-test signs of higher androgens, and — in adults, when needed — whether the ovaries have a polycystic appearance on ultrasound or an elevated AMH result. Under the Rotterdam framework used in current international guidance, adults generally need two of these three features, after other causes have been ruled out; if irregular cycles and hyperandrogenism are already present, an ultrasound is not necessarily needed to make the diagnosis. (2023 International PCOS Guideline, PMC10505534)

That "rule-out" step matters because several conditions can look like PCOS from the outside. Thyroid disease can disrupt bleeding patterns. High prolactin can interfere with ovulation. Non-classic congenital adrenal hyperplasia can raise androgens and mimic PCOS symptoms. The Endocrine Society guideline names these as key exclusions, and ACOG's guidance on hyperandrogenic adolescents similarly emphasizes checking androgen levels and screening for non-classic congenital adrenal hyperplasia with 17-hydroxyprogesterone when symptoms point that way. (Endocrine Society Clinical Practice Guideline, PMC5399492)

In practice, evaluation usually starts with your story: when periods started, how long your cycles are, whether they have stayed irregular, what acne or hair-growth changes you've noticed, whether there is scalp hair thinning, weight or skin changes, medications, family history, and pregnancy goals. A clinician may check blood pressure, body size measures, and skin signs such as acne, hirsutism, or darker velvety patches that can travel with insulin resistance. Blood work often includes androgens and tests to rule out look-alikes; clinicians may also check glucose metabolism and lipids because PCOS can overlap with metabolic risk. (Office on Women's Health)

Adolescents are handled more carefully. Puberty itself can bring acne, changing cycle length, and ovaries that look "polycystic" without the syndrome. Current international PCOS guidance says adolescents should generally have both ovulatory dysfunction and hyperandrogenism for diagnosis, and that ultrasound and AMH should not be used for adolescent diagnosis because they have poor specificity in this age group. (2023 International PCOS Guideline, PMC10505534)

The practical takeaway: if your cycles stay irregular, or irregular cycles come with acne, unwanted coarse hair growth, scalp hair thinning, dark skin patches, weight changes, or blood-sugar concerns, bring that pattern to a clinician. A simple cycle record — dates, flow, symptoms, acne flares, hair changes, and any lab results you already have — can make the visit much more useful.

Can a wearable or app diagnose PCOS?

No. PCOS is not a pattern a watch can "spot" from your wrist. In adults, diagnosis is made through a clinical workup built on the Rotterdam criteria: evidence from at least two of ovulatory dysfunction, androgen excess, and polycystic ovarian morphology, while ruling out conditions that can look similar. That workup may include hormone blood tests and ultrasound. A wearable cannot measure your testosterone or other androgens, cannot image your ovaries, and cannot check thyroid, prolactin, or 17-OH progesterone to exclude look-alikes. (2023 International PCOS Guideline, *Hum. Reprod.*, 2023)

What tracking can do is make your pattern easier to see. Irregular, missed, or unusually long cycles are one of the clues clinicians use when they're looking for ovulatory dysfunction, and a clean record of cycle length and symptoms over several months is much more useful than trying to rebuild the last year from memory. Dates help. So do notes about bleeding, acne flares, hair-growth changes, sleep, stress, energy, and symptoms that tend to cluster at certain points in your cycle. (Endocrine Society Clinical Practice Guideline, PMC5399492)

Heart-rate data needs a firm boundary. PCOS research has described group-level differences in autonomic and cardiometabolic markers, including heart rate variability and, in some studies, resting heart rate — but those are research associations, not a diagnostic test for an individual person. They can add context for a conversation with your clinician. They should not become an app alert that says, or implies, "PCOS detected." (Mirzohreh et al., *Systematic Reviews*, 2024)

That is the Welltory difference: context, not a label. Welltory can help you track cycle timing, sleep, stress, and heart-rate patterns and bring a concrete, repeatable picture to your provider — but it does not diagnose PCOS or any condition.

Can PCOS be cured?

No — but it can be managed, often very effectively. PCOS is a chronic metabolic and hormonal condition, so the goal usually isn't to "cure" it once and be done. The goal is to reduce the parts that are active in your body: irregular or absent ovulation, unpredictable periods, acne or excess hair growth from higher androgen activity, fertility challenges when pregnancy is a goal, and long-term risks tied to insulin resistance, diabetes, endometrial health, and cardiovascular health. The World Health Organization states that there is currently no cure for PCOS, but lifestyle changes, medications, and fertility treatments can reduce symptoms, support fertility, and protect longer-term health. (WHO)

That's why good PCOS care is usually built around your pattern, not the label alone. If your main issue is irregular bleeding, the plan may focus on cycle protection and predictability. If androgen symptoms are the loudest part, the plan may target skin, hair growth, or hair thinning. If you're trying to conceive, ovulation and fertility support move to the center. And because insulin resistance is recognized as a key feature of PCOS, many care plans also include lifestyle support and, when appropriate, medication — not as a moral judgment about weight, but because insulin signaling can affect androgen levels, ovulation, and long-term metabolic health. The 2023 International Evidence-based Guideline recommends a lifelong health plan that addresses reproductive, metabolic, cardiovascular, dermatologic, sleep, and psychological features of PCOS. (2023 International PCOS Guideline, PMC10505534)

This page does not recommend specific treatments, doses, or supplements (including inositol / myo-inositol, metformin, or hormonal options). Treatment decisions — including whether any medication or supplement is right for you — must be individualized by a qualified clinician. Do not start or stop any treatment based on this page. For an evidence-based overview of options, see our [PCOS treatment page](/pcos/treatment/).

When to see a doctor

See a clinician if your periods are persistently irregular, very infrequent, or absent; if you're having trouble getting pregnant; or if you're noticing signs that androgens may be running high — acne that is new, worsening, or hard to treat, unwanted facial or body hair, or thinning hair on the scalp. Also bring up metabolic clues such as unexplained weight changes or dark, velvety skin in body folds, because PCOS is not only a cycle or fertility issue: it can travel with insulin resistance, higher diabetes risk, blood pressure and cholesterol concerns, and longer-term cardiovascular risk. A good evaluation should look at the whole pattern, not just one symptom. (Mayo Clinic)

If you've been told your symptoms are "just stress" or "just your weight" for years, you're not overreacting by asking again. Delayed diagnosis and poor information are common in PCOS care, and the condition can look different from person to person. Ask specifically whether your symptoms fit the Rotterdam-style "2 of 3" framework — irregular ovulation, clinical or blood-test signs of high androgens, and polycystic-appearing ovaries — and whether you need a metabolic work-up such as blood pressure, glucose/diabetes screening, and cholesterol testing. (Gibson-Helm et al., *J. Clin. Endocrinol. Metab.*, 2017, PMC6283441)

How we made it

Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.

Trust block — authors and reviewers

Data analysis by Jane Smorodnikova — the founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.

Written by Kseniia Iaroslavtseva — COO at Welltory. She reviews scientific research and turns it into structured, readable insights.

Reviewed by Anna Elitzur — Medical Advisor & Mental Health Expert. Anna holds her medical degree and reviews health content across topics for medical accuracy and consistency with current clinical guidelines and research.

Related reading

• [PCOS symptoms](/pcos/symptoms/)

• [PCOS treatment](/pcos/treatment/)

• Related topics: [Menstrual cycle](/menstrual-cycle/)

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data